Barriers To Accessing Contraception and Cervical and Breast Cancer Screening During COVID-19: A Prospective Cohort Study |
| |
| Affiliation: | 1. Women’s Health Research Institute, Vancouver, BC;2. Department of Obstetrics and Gynaecology, University of British Columbia, Vancouver, BC;3. Department of Psychology, University of British Columbia, Vancouver, BC;4. Cancer Control Research, BC, Cancer, Vancouver, BC;5. Faculty of Health Sciences, Simon Fraser University, Burnaby, BC;6. School of Population and Public Health, University of British Columbia, Vancouver, BC;7. Department of Pediatrics, Faculty of Medicine, University of British Columbia, Vancouver, BC;8. Vaccine Evaluation Center, BC Children’s Hospital Research Institute, Vancouver, BC |
| |
| Abstract: | ObjectiveThis study sought to examine how access to contraception and cervical and breast cancer screening in British Columbia, Canada, has been affected by the COVID-19 pandemic.MethodsFrom August 2020 to March 2021, 3691 female residents of British Columbia (age 25–69 y) participated in this study. We used generalized estimating equations to analyze the proportion of females accessing contraception and the proportion having difficulty accessing contraception across the different phases of pandemic control measures, and logistic regression to analyze attendance at cervical and breast cancer screening. We added sociodemographic and biological variables individually into the models. Self-reported barriers to accessing contraception and attending screening were summarized.ResultsDuring phases with the highest pandemic controls, self-reported access to contraception was lower (OR 0.94; 95% CI 0.90–0.98; P = 0.005) and difficulty with access was higher (OR 2.74; 95% CI 1.54–4.88; P = 0.001). A higher proportion of adults aged 25–34 years reported difficulty accessing contraception than those aged 35–39 years (P < 0.0001), and participants identifying as Indigenous had higher odds of access difficulties (OR 5.56; 95% CI 2.44–12.50; P < 0.001). Of those who required screening during the COVID-19 pandemic, 62% and 54.5% did not attend at least one of their cervical or breast screening appointments, respectively. Those with a history of breast cancer had significantly higher odds of self-reporting having attended their mammogram appointment compared with those without a history of breast cancer (OR 5.62; 95% CI 2.69–13.72; P < 0.001). The most common barriers to screening were difficulty getting an appointment and appointments being considered non-urgent.ConclusionsThe COVID-19 pandemic has uniquely affected access to contraception and cancer screening participation for various subgroups. Self-reported data present potential avenues for mitigating barriers. |
| |
| Keywords: | contraception early detection of cancer COVID-19 breast neoplasms |
| 本文献已被 ScienceDirect 等数据库收录！ |
|
